The underlying cause of deficiency is the most important determinant
Ask About Basic Lab Work If shedding is noticeable, it is often worth discussing a basic set of labs to rule out common contributors, rather than guessing
With this move, Novo Nordisk strengthens its GLP-1 portfolio in India, where it already markets Rybelsus (oral semaglutide) and Wegovy (obesity management)and enters a competitive space as Eli Lillys Mounjaro is also making inroads
By binding to the GLP-1 receptors in the pancreas, it enhances the release of insulin in response to elevated blood glucose levels
Sodium Hyaluronate: Vi u th kch thc phn t nh, d dng xm nhp vo tng biu b, thnh phn ny c cng dng cung cp m cho da t su bn trong, nui dng da sn chc, gim thiu tnh trng da kh, mt nc do thiu m
Ongoing research is focused on multi-target agonists, oral drugs, and broader therapeutic applications beyond diabetes and obesity, including cardiovascular, kidney, liver, and neurodegenerative conditions